CVE-2017-17678
N/A
N/A
Summary
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Affected Software
| Vendor | Product | Version Range | Status |
|---|---|---|---|
| n/a | n/a | n/a | affected |
Weaknesses
- n/a
ADP Enrichment
CVE Program Container
Additional References
- http://bmc.com
- http://remedy.com
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
- https://seclists.org/fulldisclosure/2017/Oct/52
References
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
- https://seclists.org/fulldisclosure/2017/Oct/52
Feedback
Was this page helpful?
Glad to hear it! Please tell us how we can improve.
Sorry to hear that. Please tell us how we can improve.